U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H6N2
Molecular Weight 94.1145
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-AMINOPYRIDINE

SMILES

NC1=NC=CC=C1

InChI

InChIKey=ICSNLGPSRYBMBD-UHFFFAOYSA-N
InChI=1S/C5H6N2/c6-5-3-1-2-4-7-5/h1-4H,(H2,6,7)

HIDE SMILES / InChI

Molecular Formula C5H6N2
Molecular Weight 94.1145
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position.
2001 Jan 22
Inhibition of copper amine oxidases by pyridine-derived aldoximes and ketoximes.
2001 Nov-Dec
Structural analysis of the sugar chains of human urinary thrombomodulin.
2001 Oct
Complexation-induced unfolding of heterocyclic ureas. Simple foldamers equilibrate with multiply hydrogen-bonded sheetlike structures.
2001 Oct 31
Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore.
2001 Sep
Synthesis and structural analysis of the copper(II) complexes of N2-(2-pyridylmethyl)-2-pyridinecarboxamide.
2001 Sep
Synthesis and anti-HIV activity of some isatin derivatives.
2001 Sep-Oct
Synthesis of some new quinoline derivatives: new routes to synthesize polysubstituted 2(1H)-quinolone derivatives.
2001 Sep-Oct
Properties of some alkyl substituted phthalocyanines and related macrocycles.
2002
The nature of the receptor site for the reversible K+ channel blocking by aminopyridines.
2002 Apr 10
Analysis of fluorogenic Smith degradation products of 7-(1,3-disulfonaphtyl)amino-disaccharides for linkage position analysis of carbohydrates.
2002 Dec
Syntheses and magnetic properties of hexanuclear [Cp2Mn3(L1)4]2 and octanuclear [Mn8(L2)12(mu 4-O)2] (L1 = 2-HNC5H5N, L2 = 2-NH-3-Br-5-MeC5H3N, Cp = C5H5).
2002 Dec 21
An NMR investigation of the conformational equilibria of 2-(2'-pyridyl)ethylphosphonic acid in several solvents.
2002 Feb-Mar
Analysis of alpha-amylase-derived pyridylamino-dextran sulfate oligomers by the combination of size-exclusion and reversed-phase high-performance liquid chromatography.
2002 Jan 25
A convenient synthesis of 2-(alkylamino)pyridines.
2002 Jul 12
Potentiometric and spectrofluorimetric studies on complexation of tenoxicam with some metal ions.
2002 Jun 1
Novel vanadium(V) compounds with a layer structure: synthesis, crystal structures, and solid state NMR spectroscopy of [(VO(2))(2)(4,4'-bpy)(0.5)(4,4'-Hbpy)(XO(4))] x H(2)O (X = P and As).
2002 Jun 3
2-Aminopyridinium-succinate-succinic acid (2/1/1).
2002 Nov
Antitumor agents. 2. Synthesis, structure-activity relationships, and biological evaluation of substituted 5H-pyridophenoxazin-5-ones with potent antiproliferative activity.
2002 Nov 21
X-ray diffraction and (1)H NMR in solution: structural determination of lanthanide complexes of a Py(2)N(6)Ac(4) ligand.
2002 Oct 7
N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases.
2002 Sep
Distance dependence of electron transfer across peptides with different secondary structures: the role of Peptide energetics and electronic coupling.
2003 Apr 2
Structural modulation of Cu(I) and Cu(II) complexes of sterically hindered tripyridine ligands by the bridgehead alkyl groups.
2003 Feb 24
2-aminopyridinium benzoate.
2003 Jan
Selective complex formation of some chromogenic calix[4]arene derivatives detected by Fourier transform infrared spectroscopy 1. Solution experiments.
2003 Jan 1
NMR evaluation of the configurational stability of Cu(I) complexes.
2003 Jan 27
Could redox-switched binding of a redox-active ligand to a copper(II) centre drive a conformational proton pump gate? A synthetic model study.
2003 Jan 3
Structural chemistry and In vitro antitubercular activity of acetylpyridine benzoyl hydrazone and its copper complex against Mycobacterium smegmatis.
2003 Jan 6
Localization of defined carbohydrate epitopes in bovine polysialylated NCAM.
2003 Jan-Feb
N-glycan structures of human transferrin produced by Lymantria dispar (gypsy moth) cells using the LdMNPV expression system.
2003 Jul
Speciation study of the anti-inflammatory drug tenoxicam (Htenox) with Cu(II): X-ray crystal structure of [Cu(tenox)(2)(py)(2)].EtOH.
2003 Jun 1
Plant cultured cells expressing human beta1,4-galactosyltransferase secrete glycoproteins with galactose-extended N-linked glycans.
2003 Mar
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:20:48 UTC 2023
Edited
by admin
on Fri Dec 15 17:20:48 UTC 2023
Record UNII
WSX981HEWU
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-AMINOPYRIDINE
HSDB  
Systematic Name English
MEPYRAMINE MALEATE IMPURITY C [EP IMPURITY]
Common Name English
NSC-431
Code English
.ALPHA.-AMINOPYRIDINE
MI  
Common Name English
TENOXICAM IMPURITY A [EP IMPURITY]
Common Name English
.ALPHA.-AMINOPYRIDINE [MI]
Common Name English
2-PYRIDINAMINE
Systematic Name English
PYRIDIN-2-AMINE
Systematic Name English
PIROXICAM RELATED COMPOUND A [USP-RS]
Common Name English
2-AMINOPYRIDINE [HSDB]
Common Name English
AMINOPYRIDINE, 2-
Systematic Name English
PIROXICAM IMPURITY A [EP IMPURITY]
Common Name English
Code System Code Type Description
SMS_ID
100000142926
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
HSDB
2068
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
MERCK INDEX
m1739
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID0024505
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
CAS
504-29-0
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
PUBCHEM
10439
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
MESH
C032439
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
NSC
431
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
WIKIPEDIA
2-AMINOPYRIDINE
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
ECHA (EC/EINECS)
207-988-4
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
RS_ITEM_NUM
1544519
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
FDA UNII
WSX981HEWU
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
EVMPD
SUB117598
Created by admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity A = 0.2
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
For the calculation of contents, multiply the peak areas by 0.6
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY